Analgesic efficacy of a laparoscopic-guided transversus abdominis plane block versus no transversus abdominis plane block in bariatric gastric bypass surgery a retrospective analysis among 332 individuals

一项对332例接受减肥胃旁路手术的患者进行的回顾性分析,比较了腹腔镜引导下腹横肌平面阻滞与不进行腹横肌平面阻滞的镇痛效果。

阅读:1

Abstract

BACKGROUND: To reduce opioid consumption and improve early mobility, the administration of a transversus abdominis plane block (TAP) was introduced in abdominal surgery decades ago. But the usefulness of this nerve block prior to laparoscopic Roux-Y gastric bypass (LRYGB) in patients with obesity is still under debate. Hence, the study at hand was conducted. METHODS: In 2023 a retrospective single-centre analysis among patients who did or did not receive a laparoscopic (L) TAP block prior to LRYGB was performed. The primary objective was the early postoperative pain level (1 h) using the visual analog scale (VAS) after LRYGB. Main secondary objectives were the determination of the pain level from 1 to 80 h after surgery and the cumulative postoperative painkiller use. RESULTS: A total of 111 individuals received and 202 did not receive a L-TAP block prior to LRYGB. The groups were homogeneous with respect to age, gender distribution and Body Mass Index. No L-TAP related complications occurred. After multivariate analysis the administration of the nerve block had no effect on relevant pain (VAS ≥ 6) from one to 80 h after LRYGB. One hour after surgery, the individuals who received the L-TAP suffered, with significance, from less pain (VAS score 2.77 vs. 3.84: p < 0.001) in comparison to those who did not receive the nerve block. No difference was revealed in terms of cumulative postoperative opioid painkiller use. CONCLUSION: The L-TAP block is a safe procedure and sufficiently reduces post-operative pain one hour after gastric bypass surgery, but does not bring any benefits in the further course.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。